14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for ANVS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.73 7.10 %
R2 5.59 4.53 %
R1 5.51 2.94 %
Current price: 5.35
Support S1 5.23 -2.20 %
S2 5.15 -3.78 %
S3 5.01 -6.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.11 14.21 %
R2 5.57 4.11 %
R1 5.45 1.87 %
Current price 5.35
Support S1 5.18 -3.18%
S2 0 .
S3 0 .

ANVS Predictions History

1 year ago
MikeH predicted that ANVS for 2023-02-02 is going

Rank:

2 years ago
RamboRex3000 predicted that ANVS for 2021-07-30 is going $44.20 (28.38%)

2 years ago
JS predicted that ANVS for 2021-07-30 is going $53.60 (55.68%)

2 years ago
JS predicted that ANVS for 2021-07-16 is going $95.40 (-8.26%)

2 years ago
Patricia Thompson predicted that ANVS for 2021-07-16 is going

Rank:

3 years ago
hubert.czlapinski.222355 predicted that ANVS for 2021-03-15 is going $70.35 (139.69%)

Rank:

3 years ago
JS predicted that ANVS for 2021-02-26 is going $26.50 (3.64%)

3 years ago
JS predicted that ANVS for 2020-07-08 is going $6.16 (-8.47%)

Click to get the best stock tips daily for free!

About Annovis Bio, Inc.

Annovis Bio. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote... ANVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT